Vlahovich KP, Sood A. A 2019 update on occupational lung diseases: a narrative review. Pulm Ther. 2021;7(1):75–87. https://doi.org/10.1007/s41030-020-00143-4.
Glaser MS, Webber MP, Zeig-Owens R, Weakley J, Liu X, Ye F, et al. Estimating the time interval between exposure to the World Trade Center disaster and incident diagnoses of obstructive airway disease. Am J Epidemiol. 2014;180(3):272–9. https://doi.org/10.1093/aje/kwu137.
Article PubMed PubMed Central Google Scholar
Niles JK, Webber MP, Cohen HW, Hall CB, Zeig-Owens R, Ye F, et al. The respiratory pyramid: from symptoms to disease in World Trade Center exposed firefighters. Am J Ind Med. 2013;56(8):870–80. https://doi.org/10.1002/ajim.22171.
Article PubMed PubMed Central Google Scholar
Guidotti TL, Prezant D, de la Hoz RE, Miller A. The evolving spectrum of pulmonary disease in responders to the World Trade Center tragedy. Am J Ind Med. 2011;54(9):649–60. https://doi.org/10.1002/ajim.20987.
Mazzei MA, Sartorelli P, Bagnacci G, Gentili F, Sisinni AG, Fausto A, et al. Occupational lung diseases: underreported diagnosis in radiological practice. Semin Ultrasound CT MR. 2019;40(1):36–50. https://doi.org/10.1053/j.sult.2018.10.019.
Anderson SE, Long C, Dotson GS. Occupational allergy. Eur Med J (Chelmsf). 2017;2(2):65–71.
Cormier M, Lemiere C. Occupational asthma. Int J Tuberc Lung Dis. 2020;24(1):8–21. https://doi.org/10.5588/ijtld.19.0301.
Article CAS PubMed Google Scholar
Raulf M. Occupational respiratory allergy: risk factors, diagnosis, and management. Handb Exp Pharmacol. 2022;268:213–25. https://doi.org/10.1007/164_2021_472.
Article CAS PubMed Google Scholar
Arts J. How to assess respiratory sensitization of low molecular weight chemicals? Int J Hyg Environ Health. 2020;225:113469. https://doi.org/10.1016/j.ijheh.2020.113469.
Article CAS PubMed Google Scholar
Vandenplas O, Godet J, Hurdubaea L, Rifflart C, Suojalehto H, Wiszniewska M, et al. Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma? Allergy. 2019;74(2):261–72. https://doi.org/10.1111/all.13542.
Lipinska-Ojrzanowska A, Nowakowska-Swirta E, Wiszniewska M, Walusiak-Skorupa J. Bronchial response to high and low molecular weight occupational inhalant allergens. Allergy Asthma Immunol Res. 2020;12(1):164–70. https://doi.org/10.4168/aair.2020.12.1.164.
Article CAS PubMed Google Scholar
Platts-Mills TAE, Schuyler AJ, Erwin EA, Commins SP, Woodfolk JA. IgE in the diagnosis and treatment of allergic disease. J Allergy Clin Immunol. 2016;137(6):1662–70. https://doi.org/10.1016/j.jaci.2016.04.010.
Article CAS PubMed PubMed Central Google Scholar
Breiteneder H, Diamant Z, Eiwegger T, Fokkens WJ, Traidl-Hoffmann C, Nadeau K, et al. Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care. Allergy. 2019;74(12):2293–311. https://doi.org/10.1111/all.13851.
Sahiner U, Akdis M, Akdis CA. 1 - Introduction to mechanisms of allergic diseases. In: O’Hehir RE, Holgate ST, Khurana Hershey GK, Sheikh A, editors. Allergy Essentials. 2nd ed. Philadelphia: Elsevier; 2022. p. 1–24.
Alvaro-Lozano M, Akdis CA, Akdis M, Alviani C, Angier E, Arasi S, et al. EAACI allergen immunotherapy user’s guide. Pediatr Allergy Immunol. 2020;31(Suppl 25):1–101. https://doi.org/10.1111/pai.13189.
Article PubMed PubMed Central Google Scholar
Fulkerson PC, Rothenberg ME. Eosinophil development, disease involvement, and therapeutic suppression. Adv Immunol. 2018;138:1–34. https://doi.org/10.1016/bs.ai.2018.03.001.
Article CAS PubMed Google Scholar
Angkasekwinai P, Dong C. IL-9-producing T cells: potential players in allergy and cancer. Nat Rev Immunol. 2021;21(1):37–48. https://doi.org/10.1038/s41577-020-0396-0.
Article CAS PubMed Google Scholar
Kabashima K, Irie H. Interleukin-31 as a clinical target for pruritus treatment. Front Med (Lausanne). 2021;8:638325. https://doi.org/10.3389/fmed.2021.638325.
Article PubMed PubMed Central Google Scholar
Blomme EE, Provoost S, Bazzan E, Van Eeckhoutte HP, Roffel MP, Pollaris L, et al. Innate lymphoid cells in isocyanate-induced asthma: role of microRNA-155. Eur Respir J. 2020. https://doi.org/10.1183/13993003.01289-2019.
Karta MR, Broide DH, Doherty TA. Insights into group 2 innate lymphoid cells in human airway disease. Curr Allergy Asthma Rep. 2016;16(1):8. https://doi.org/10.1007/s11882-015-0581-6.
Article CAS PubMed PubMed Central Google Scholar
Stanbery AG, Shuchi S, von Jakob M, Tait Wojno ED, Ziegler SF. TSLP, IL-33, and IL-25: not just for allergy and helminth infection. J Allergy Clin Immunol. 2022;150(6):1302–13. https://doi.org/10.1016/j.jaci.2022.07.003.
Article CAS PubMed Google Scholar
Zheng H, Zhang Y, Pan J, Liu N, Qin Y, Qiu L, et al. The role of type 2 innate lymphoid cells in allergic diseases. Front Immunol. 2021;12:586078. https://doi.org/10.3389/fimmu.2021.586078.
Article CAS PubMed PubMed Central Google Scholar
Martinez-Gonzalez I, Matha L, Steer CA, Ghaedi M, Poon GF, Takei F. Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation. Immunity. 2016;45(1):198–208. https://doi.org/10.1016/j.immuni.2016.06.017.
Article CAS PubMed Google Scholar
Kucuksezer UC, Ozdemir C, Akdis M, Akdis CA. Precision/personalized medicine in allergic diseases and asthma. Arch Immunol Ther Exp (Warsz). 2018;66(6):431–42. https://doi.org/10.1007/s00005-018-0526-6.
Moon TC, Befus AD, Kulka M. Mast cell mediators: their differential release and the secretory pathways involved. Front Immunol. 2014;5:569. https://doi.org/10.3389/fimmu.2014.00569.
Article CAS PubMed PubMed Central Google Scholar
Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350–400. https://doi.org/10.1016/S0140-6736(17)30879-6.
Lummus ZL, Wisnewski AV, Bernstein DI. Pathogenesis and disease mechanisms of occupational asthma. Immunol Allergy Clin North Am. 2011;31(4):699–716, vi. https://doi.org/10.1016/j.iac.2011.07.008.
Article PubMed PubMed Central Google Scholar
Lemiere C, Lavoie G, Doyen V, Vandenplas O. Irritant-induced asthma. J Allergy Clin Immunol Pract. 2022;10(11):2799–806. https://doi.org/10.1016/j.jaip.2022.06.045.
Article CAS PubMed Google Scholar
Froidure A, Mouthuy J, Durham SR, Chanez P, Sibille Y, Pilette C. Asthma phenotypes and IgE responses. Eur Respir J. 2016;47(1):304–19. https://doi.org/10.1183/13993003.01824-2014.
Article CAS PubMed Google Scholar
Sinyor B, Concepcion Perez L. Pathophysiology of asthma. StatPearls. Treasure Island (FL) 2022.
Liu MC, Hubbard WC, Proud D, Stealey BA, Galli SJ, Kagey-Sobotka A, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis. 1991;144(1):51–8. https://doi.org/10.1164/ajrccm/144.1.51.
Article CAS PubMed Google Scholar
Stewart AG, Tomlinson PR, Fernandes DJ, Wilson JW, Harris T. Tumor necrosis factor alpha modulates mitogenic responses of human cultured airway smooth muscle. Am J Respir Cell Mol Biol. 1995;12(1):110–9. https://doi.org/10.1165/ajrcmb.12.1.7529028.
Article CAS PubMed Google Scholar
Chapman DG, Irvin CG. Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come. Clin Exp Allergy. 2015;45(4):706–19. https://doi.org/10.1111/cea.12506.
Article CAS PubMed PubMed Central Google Scholar
Zou Y, Song W, Zhou L, Mao Y, Hong W. House dust mite induces Sonic hedgehog signaling that mediates epithelial-mesenchymal transition in human bronchial epithelial cells. Mol Med Rep. 2019;20(5):4674–82. https://doi.org/10.3892/mmr.2019.10707.
Article CAS PubMed PubMed Central Google Scholar
• Hough KP, Curtiss ML, Blain TJ, Liu RM, Trevor J, Deshane JS, et al. Airway remodeling in asthma. Front Med (Lausanne). 2020;7:191. https://doi.org/10.3389/fmed.2020.00191. This is a thorough review describing mechanisms of disease progression associated with asthma exacerbation and allergic exposure. This discusses cutting-edge perspectives to further inform allergic respiratory disease mechanisms.
Evans CM, Kim K, Tuvim MJ, Dickey BF. Mucus hypersecretion in asthma: causes and effects. Curr Opin Pulm Med. 2009;15(1):4–11. https://doi.org/10.1097/MCP.0b013e32831da8d3.
Article CAS PubMed PubMed Central Google Scholar
Sumi Y, Foley S, Daigle S, L’Archeveque J, Olivenstein R, Letuve S, et al. Structural changes and airway remodelling in occupational asthma at a mean interval of 14 years after cessation of exposure. Clin Exp Allergy. 2007;37(12):1781–7. https://doi.org/10.1111/j.1365-2222.2007.02828.x.
留言 (0)